You searched for "information"
Birmingham Optical Achieves UKAS ISO 9001 Certification
5 August 2025
|
Company Profiles, Awards, Conferences & Anniversaries
Birmingham Optical, a leading UK provider of optical equipment and services, has been awarded the prestigious UKAS ISO 9001 certification, a globally recognised standard for quality management systems (QMS). This milestone reflects the company’s dedication to excellence, consistency, and customer...
Cataract surgery in patients with Vogt-Koyanagi-Harada
1 February 2019
| Tasmin Berman
|
EYE - Vitreo-Retinal
This retrospective, interventional case series of 286 patients (408 eyes) assessed visual outcome and prognostic factors in patients with Vogt-Koyanagi-Harada (VKH) undergoing cataract surgery between September 2008 and December 2017. Two groups were reviewed. The first group (352 eyes) had...
Scottish Glaucoma Symposium 2024
21 June 2024
by Nivi Aravind, Y5 Medical Student, University of Edinburgh, UK. The 22nd Scottish Glaucoma Symposium enlivened the prestigious Royal College of Surgeons in Edinburgh on 21 June in what was a delightful meeting of minds. The day’s programme was impeccably...
Review of extraocular muscle biopsies and utility of biopsy in extraocular muscle enlargement
This is a retrospective case series study from Melbourne, Australia, of 93 patients with extraocular muscle (EOM) enlargement who underwent an EOM biopsy between March 1992 and January 2017. Statistical analysis was performed to compare the data between patients with...MicroPulse Transscleral Laser Therapy: A Prospective UK Study
13 September 2024
|
NICE, Laser therapy, glaucoma, Eduardo Normando, education, study, research, Philip Bloom
Register now to participate. Eagerly anticipated and now underway – a landmark UK medical research study on MicroPulse® Transscleral Laser Therapy (MPTLT) for the treatment of glaucoma using Iridex’ Cyclo G6® Laser and the MicroPulse P3® Delivery Device. A NICE-compliant...
An uncommon late postoperative complication of combined cataract surgery and intravitreal triamcinolone injection
1 December 2014
| Pouya Alaghband, Ambreen Kalhoro, Toams Cudrnak, Ishtyak Mahomed, Nigel James
|
EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Case report A 64-year-old female with diabetic maculopathy (DMO) underwent phacoemulsification with intraocular lens (IOL) implantation in her right eye combined with intravitreal triamcinolone (IVTA). Diabetes control was poor with HbA1c (IFCC) of 119mmol/mol and blood sugar level of 27mmol/L....
The role of aspirin in the treatment of NAION: Benefits and controversies
4 December 2024
| Ali Yagan
|
EYE - Neuro-ophthalmology
Non-arteritic anterior ischaemic optic neuropathy (NAION) is the most common acute optic neuropathy in individuals over 50 with estimated prevalence of 2–10 per 100,000 people, characterised by sudden, unilateral vision loss due to ischaemic injury to the optic nerve head....
Guide to Gaining Approval for a Clinical Study
1 April 2014
| Vanessa Cobb, Pier D Lambiase
|
EYE - General
This article focuses on gaining approval for clinical research involving NHS patients, although the principles can be applied to other types of research. The intention is to give an overview of the requirements for setting up a research study, but...
Intravitreal Ziv-Aflibercept: safety analysis
7 December 2020
| Su Young
|
EYE - Vitreo-Retinal
Ziv-Aflibercept (Zaltrap; Sanofi-Aventis U.S LLS, Bridgewater, NJ) was originally introduced as an intravenous formulation for metastatic colorectal cancer. The adoption of Ziv-Aflibercept in ophthalmic practice was similar to bevacizumab, and reports have previously examined one to two year visual outcomes...
An educational intervention to improve adherence to high-dosage patching regimen for amblyopia
This is a randomised trial of patients recruited between the periods of March 2006 and March 2008 from ophthalmology clinics in the Leicestershire area. A total of 62 children with newly diagnosed amblyopia were allocated randomly into two treatment arms...Emerging developments in dry eye
1 August 2017
| Rod McNeil
|
EYE - Cornea
An estimated 344 million people worldwide suffer from dry eye [1]. This chronic syndrome is characterised by a vicious cycle of tear film hyperosmolarity, tear instability and corneal stress, leading to increased friction, inflammation, ocular surface damage and decreased visual...
Théa Pharmaceuticals are excited to be attending RCOphth Congress 2023 with two innovative new products.
22 May 2023
|
Research & Development, Awards, Conferences & Anniversaries
This year Théa will also have two stands – one right by the registration desk which will be focused on product sampling and a larger stand inside the main exhibition hall which will showcase the wider product range.